PL1651596T3 - Nowe pochodne 4,4’ - ditiobis(3-aminobutano-1-sulfonianów) i zawierające je kompozycje - Google Patents

Nowe pochodne 4,4’ - ditiobis(3-aminobutano-1-sulfonianów) i zawierające je kompozycje

Info

Publication number: PL1651596T3
Authority: PL; Poland
Prior art keywords: aminobutane; dithiobis; sulfonates; compositions; same
Prior art date: 2003-08-06

Application number

PL04786279T

Other languages

English (en)

Inventor

Bernard Pierre Roques

Nicolas Inguimbert

Marie-Claude Fournie-Zaluski

Pierre Corvol

Catherine Llorens-Cortes

Original Assignee

Inst Nat Sante Rech Med

Univ Paris Descartes

Centre Nat Rech Scient

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-08-06

Filing date

2004-08-06

Publication date

2010-08-31

2004-08-06 Application filed by Inst Nat Sante Rech Med, Univ Paris Descartes, Centre Nat Rech Scient filed Critical Inst Nat Sante Rech Med

2010-08-31 Publication of PL1651596T3 publication Critical patent/PL1651596T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/66—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/32—Esters thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Hematology (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL04786279T 2003-08-06 2004-08-06 Nowe pochodne 4,4’ - ditiobis(3-aminobutano-1-sulfonianów) i zawierające je kompozycje PL1651596T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0309700A FR2858617A1 (fr)	2003-08-06	2003-08-06	Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant
EP04786279A EP1651596B1 (fr)	2003-08-06	2004-08-06	Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
PCT/FR2004/002106 WO2005014535A1 (fr)	2003-08-06	2004-08-06	Derives de 4,4’-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant

Publications (1)

Publication Number	Publication Date
PL1651596T3 true PL1651596T3 (pl)	2010-08-31

Family

ID=34073059

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04786279T PL1651596T3 (pl)	2003-08-06	2004-08-06	Nowe pochodne 4,4’ - ditiobis(3-aminobutano-1-sulfonianów) i zawierające je kompozycje

Country Status (14)

Country	Link
US (1)	US7582797B2 (pl)
EP (1)	EP1651596B1 (pl)
JP (1)	JP4718461B2 (pl)
AT (1)	ATE455097T1 (pl)
CA (1)	CA2533432C (pl)
CY (1)	CY1109950T1 (pl)
DE (1)	DE602004025119D1 (pl)
DK (1)	DK1651596T3 (pl)
ES (1)	ES2339354T3 (pl)
FR (1)	FR2858617A1 (pl)
PL (1)	PL1651596T3 (pl)
PT (1)	PT1651596E (pl)
SI (1)	SI1651596T1 (pl)
WO (1)	WO2005014535A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2931151A1 (fr) *	2008-05-13	2009-11-20	Pharmaleads Soc Par Actions Si	Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
EP2326619B1 (en)	2008-08-01	2019-02-27	Bioxiness Pharmaceuticals, Inc.	Methionine analogs and methods of using same
EP2439192A1 (en) *	2010-10-07	2012-04-11	Quantum Genomics	Method for the preparation of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid)
CA2859704C (en)	2011-12-21	2020-04-28	Quantum Genomics	Combination of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent
EP2722327A1 (en) *	2012-10-22	2014-04-23	Quantum Genomics	Crystalline phase of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) with L-lysine
CA2964474A1 (en) *	2014-10-17	2016-04-21	University Of Florida Research Foundation	Novel small molecule anticancer agents
TW202100146A (zh) *	2019-03-11	2021-01-01	法商量子基因科技有限公司	用於治療高血壓或心衰竭的化合物及包含其之組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CO5021134A1 (es) *	1998-05-01	2001-03-27	Abbott Lab	Inhibidores beta-aminoacidos substituidos de aminopeptida- sa-2 metionina
US6919307B2 (en) *	2000-11-01	2005-07-19	Praecis Pharmaceuticals, Inc.	Therapeutic agents and methods of use thereof for the modulation of angiogenesis
EP1381360A4 (en) *	2001-03-29	2009-12-02	Smithkline Beecham Corp	COMPOUNDS AND METHODS FOR INHIBITING METAP2 IN MAMMALS

2003
- 2003-08-06 FR FR0309700A patent/FR2858617A1/fr not_active Withdrawn
2004
- 2004-08-06 WO PCT/FR2004/002106 patent/WO2005014535A1/fr not_active Ceased
- 2004-08-06 PL PL04786279T patent/PL1651596T3/pl unknown
- 2004-08-06 EP EP04786279A patent/EP1651596B1/fr not_active Expired - Lifetime
- 2004-08-06 DK DK04786279.2T patent/DK1651596T3/da active
- 2004-08-06 US US10/567,362 patent/US7582797B2/en not_active Expired - Lifetime
- 2004-08-06 AT AT04786279T patent/ATE455097T1/de active
- 2004-08-06 PT PT04786279T patent/PT1651596E/pt unknown
- 2004-08-06 DE DE602004025119T patent/DE602004025119D1/de not_active Expired - Lifetime
- 2004-08-06 ES ES04786279T patent/ES2339354T3/es not_active Expired - Lifetime
- 2004-08-06 JP JP2006522380A patent/JP4718461B2/ja not_active Expired - Fee Related
- 2004-08-06 CA CA2533432A patent/CA2533432C/fr not_active Expired - Fee Related
- 2004-08-06 SI SI200431385T patent/SI1651596T1/sl unknown
2010
- 2010-03-23 CY CY20101100285T patent/CY1109950T1/el unknown

Also Published As

Publication number	Publication date
JP2007501204A (ja)	2007-01-25
CA2533432C (fr)	2013-05-21
US20060205695A1 (en)	2006-09-14
FR2858617A1 (fr)	2005-02-11
ATE455097T1 (de)	2010-01-15
SI1651596T1 (sl)	2010-06-30
CY1109950T1 (el)	2014-09-10
US7582797B2 (en)	2009-09-01
WO2005014535A1 (fr)	2005-02-17
ES2339354T3 (es)	2010-05-19
EP1651596A1 (fr)	2006-05-03
EP1651596B1 (fr)	2010-01-13
CA2533432A1 (fr)	2005-02-17
PT1651596E (pt)	2010-04-16
DE602004025119D1 (de)	2010-03-04
JP4718461B2 (ja)	2011-07-06
DK1651596T3 (da)	2010-05-10

Publication	Publication Date	Title
BE2017C018I2 (pl)	2021-02-04
MY141661A (en)	2010-05-31	17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
MXPA03010207A (es)	2004-03-10	Nuevas 4-anilinoquinolin-3-carboxamidas.
YU84603A (sh)	2006-03-03	Novi inhibitori tirozin kinaze
TNSN07235A1 (en)	2008-11-21	Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
PL366590A1 (pl)	2005-02-07	Nowe związki jako środki przeciwzapalne, immunomodulujące i przeciwproliferacyjne
TW200510325A (en)	2005-03-16	2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
WO2004004657A3 (en)	2004-11-04	Hiv integrase inhibitors
MXPA04003886A (es)	2004-07-08	Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
DE60112330D1 (en)	2005-09-01	Pyrazolopyridinderivate
ZA200404752B (en)	2005-04-26	6-aminomorphinane derivatives method for the production and use thereof
CY1109950T1 (el)	2014-09-10	Νεα παραγωγα 4,4-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικων) και συνθεσεις που τα περιεχουν
MXPA04002282A (es)	2005-03-07	Nuevos compuestos y preparaciones como inhibidores de la catepsina.
MXPA03010766A (es)	2005-03-07	Nuevos compuestos y composiciones como inhibicores de las catepsinas.
MXPA04003755A (es)	2004-07-23	Endoprotesis vasculares.
MXPA04005809A (es)	2004-09-13	Inhibidores de proteinas quinasas.
UA88867C2 (ru)	2009-12-10	Композиция, которая содержит модафинил, и ее применение
GB0229081D0 (en)	2003-01-15	Multifunctional cationic photoinitiators, their preparation and use
DE60201074D1 (en)	2004-09-30	Pyrazolopyridinderivate
HRP20050082A2 (en)	2005-06-30	6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
MXPA04003910A (es)	2004-07-23	Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar.
MXPA03005374A (es)	2004-03-26	Carbazoles antitumorales.
MXPA04005151A (es)	2004-08-11	Compuestos terapeuticos.
TW200503672A (en)	2005-02-01	2-aminobenzoyl derivatives
YU34604A (sh)	2006-08-17	Oligopeptidi kao inhibitori katepsina s i kompozicije koje ih sadrže